DOCUMENT

Gene therapy treatments for two forms of BD are trialled in affected sheep. The BD flock grows to about 200 sheep. Those receiving the gene therapy are living longer and displaying less cognitive decline. €k in NF grants €k in NF grants Years ahead The gene therapy developed in New Zealand is approved for human trials by the US Food and Drug Administration (FDA). Clinical trials start in the United States and United Kingdom. Two new BD projects are awarded to Lincoln and Otago Universities. “We’re hopeful that our gene therapy, which is proving so successful in sheep, will be just as effective in children. “ Dr NadiaMitchell Neurological Foundation of New Zealand 